Budget 2026 has again left a prostate cancer screening trial unfunded, and the charity that has spent more than three years asking for it says the decision will cost New Zealand men their lives.
The Prostate Cancer Foundation had asked the Government for about 6.4 million dollars over four years to run two regional pilots for the early detection of the disease. In the context of a health budget measured in the tens of billions, the Foundation argues, that is a tiny sum for a programme it says could start saving hundreds of lives almost immediately. When the Budget was handed down on 28 May with no money attached, the response from the charity was blunt.
“I would love to use the word disappointed. In fact, I’m more than disappointed. I’m absolutely gutted,” Foundation President Danny Bedingfield told RNZ. He said the two pilots were modest and well supported by clinicians. “That’s all we really need to start saving hundreds of lives.”
The numbers behind the request are stark. More than 4000 New Zealand men are diagnosed with prostate cancer every year and more than 700 die from it, making it one of the most common cancers affecting men in the country. The Foundation also points to independent polling of 1000 eligible voters, which found that 84 percent of New Zealanders support the development of a national screening programme. That is a level of cross party public agreement most policies never reach.
Bedingfield said the gap between that support and the Budget result was hard to accept. “We have now been talking to successive governments for more than three years about funding two regional pilots,” he said. “In the context of a multi-billion-dollar health budget, this is a drop in the bucket for the Government, but a kick in the guts for Kiwi men and their families.” He added that the case had already been made on every front that should matter to a Cabinet. “The clinical support is there, the need is there, and the cost is modest. What appears to be missing is the political will to act.”
He also framed the decision in plain human terms rather than as a line in a spending document. “These are fathers, husbands, brothers, sons, workmates and friends. Their lives matter,” he said, before asking the question the Foundation has put to ministers for years. “Why does cancer specific to men continue to be overlooked?”
The Government has not closed the door entirely. Health Minister Simeon Brown said he wanted to see a real improvement for men affected by prostate cancer and that he had asked officials at the Ministry of Health to develop options to progress a pilot where it makes sense. That falls well short of a funded commitment, and it leaves the timing of any programme uncertain. For a charity that has watched three Budgets pass without progress, a promise to look at options reads as familiar rather than reassuring.
The frustration is sharpened by what the same Budget did deliver for another cancer. Budget 2026 lowered the eligibility age for the national bowel screening programme from 58 to 56, with the change due to take effect in September, a step the Government says brings New Zealand closer into line with Australia. That decision shows the money exists to expand early detection when the political will is there. Prostate campaigners ask why their own disease, which kills a comparable number of New Zealanders each year, keeps missing out.
Even the bowel screening move drew criticism for not going far enough. Labour health spokesperson Dr Ayesha Verrall said there was no good reason the Government could not fully deliver on its election promise to match Australia’s screening age this term, and warned that lowering the age means little if the system cannot keep up. She said people who screen positive need to actually receive colonoscopies, and that this is under serious strain because of a blowout in waiting lists. Without extra resources for the teams doing the procedures, she argued, an earlier invitation to be screened is only half a programme.
Taken together, the two decisions sketch the shape of the health debate heading into an election year. The Government can point to a real expansion of bowel screening and to a Budget it says is focused on better cancer outcomes. Its critics, and a growing list of patient charities, counter that the choices reveal which conditions get priority and which are asked to wait. Men’s health advocates say prostate cancer has spent too long in the second category, and they intend to keep the pressure on through the campaign.
How the major parties treat cancer screening, hospital waiting lists and health funding will be one of the clearest dividing lines when New Zealanders go to the polls later this year. If you want to see where the parties stand before you cast your vote, you can compare their positions using our voting tool.
What do you think? Should a prostate cancer screening pilot have made the cut in Budget 2026, and is men’s health getting a fair share of the health dollar? Have your say in the comments below.
This article was written by AI, briefed to report the facts, hopefully without some of the bias people bring to the job 🙂
Leave a Reply